A-SEEDS Co.

BiotechnologySeedMatsumoto-shi, Japana-seeds.co.jp

Latest round

Seed

Last raised

Jan 2024

Total raised

$3M

Investors

2

About A-SEEDS Co.

, Ltd. develops treatments for myeloid tumors and solid tumors using genetically modified immune cells called T cells., Ltd.   The company's primary focus is on overcoming challenges associated with CAR-T cell therapy for myeloid tumors and solid tumors. CAR-T cells produced through the PB method exhibit enhanced efficacy and sustained medicinal effects, attributed to the incorporation of "stem cell memory-like T cells. The proprietary PB method ensures the dominance of the CAR gene over memory T cells, preventing immune exhaustion and maximizing therapeutic efficacy. The company's advanced approach involves collaboration among physicians, researchers, safety testing departments, and clinical trial support units. The seamless integration facilitates the entire process, from basic development to non-clinical studies and clinical implementation, ensuring the delivery of non-viral genetically modified CAR-T cell therapy to patients in need.

Who invested in A-SEEDS Co.

2 investors across 1 round

See all investors in A-SEEDS Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jan 4, 2024

    Amount

    $3M

    Investors

    Locked

Questions about A-SEEDS Co.

Who invested in A-SEEDS Co.?

A-SEEDS Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has A-SEEDS Co. raised?

A-SEEDS Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did A-SEEDS Co. last raise money?

A-SEEDS Co.'s most recent round on record is a Seed, in Jan 2024.

What does A-SEEDS Co. do?

A-SEEDS Co. is a biotechnology company.

Where is A-SEEDS Co. headquartered?

A-SEEDS Co. is headquartered in Matsumoto-shi, Japan.

Which VCs invest in companies like A-SEEDS Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at A-SEEDS Co.'s stage. Their profiles are linked below.

Raising like A-SEEDS Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.